Publication: Detection of HBV genome by gene amplification method in HBsAg negative blood donors
Submitted Date
Received Date
Accepted Date
Issued Date
1999-05-01
Copyright Date
Announcement No.
Application No.
Patent No.
Valid Date
Resource Type
Edition
Resource Version
Language
File Type
No. of Pages/File Size
ISBN
ISSN
01252208
eISSN
DOI
Scopus ID
WOS ID
Pubmed ID
arXiv ID
Call No.
Other identifier(s)
2-s2.0-0033128398
Journal Title
Volume
Issue
item.page.oaire.edition
Start Page
End Page
Access Rights
Access Status
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Physical Location
Bibliographic Citation
Journal of the Medical Association of Thailand. Vol.82, No.5 (1999), 490-495
Citation
Pisamai Bodhiphala, Pimol Chiewsilp, Somchai Chaturachumroenchai, Prasong Pruksananonda (1999). Detection of HBV genome by gene amplification method in HBsAg negative blood donors. Retrieved from: https://hdl.handle.net/20.500.14594/25656.
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Detection of HBV genome by gene amplification method in HBsAg negative blood donors
Alternative Title(s)
Author's Affiliation
Author's E-mail
Editor(s)
Editor's Affiliation
Corresponding Author(s)
Creator(s)
Compiler
Advisor(s)
Illustrator(s)
Applicant(s)
Inventor(s)
Issuer
Assignee
Other Contributor(s)
Series
Has Part
Abstract
The incidence of post-transfusion hepatitis has been reduced greatly by screening blood donors for hepatitis B surface antigen (HBsAg). However, hepatitis B virus infection still accounts for a certain number of cases of post-transfusion hepatitis. The purpose of this study was to detect HBV DNA in the HBsAg negative blood samples by using nested PCR with two primer pairs specific to core region. Two hundreds blood samples from HBsAg negative donors, and 14 samples from HBsAg positive donors were provided by the blood bank of Ramathibodi Hospital. The results showed that HBV DNA was detected in all 14 HBsAg positive blood samples and in 7 (3.5%) of 200 HBsAg negative blood samples. This study showed that the absence of HBsAg in otherwise apparently healthy individuals may not be enough to ensure lack of circulating HBV. The more sensitive ELISA technique is still in need. Otherwise, the safety of blood transfusion can be enhanced by careful selection of blood donors and careful consideration of risks and benefit of the patients who need blood transfusions.